GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioNxt Solutions Inc (XCNQ:BNXT) » Definitions » Debt-to-Asset

BioNxt Solutions (XCNQ:BNXT) Debt-to-Asset : 6.49 (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is BioNxt Solutions Debt-to-Asset?

BioNxt Solutions's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was C$5.12 Mil. BioNxt Solutions's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was C$0.00 Mil. BioNxt Solutions's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Mar. 2024 was C$0.79 Mil. BioNxt Solutions's debt to asset for the quarter that ended in Mar. 2024 was 6.49.


BioNxt Solutions Debt-to-Asset Historical Data

The historical data trend for BioNxt Solutions's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioNxt Solutions Debt-to-Asset Chart

BioNxt Solutions Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Asset
Get a 7-Day Free Trial 0.16 0.40 0.56 2.71 3.86

BioNxt Solutions Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.71 1.45 2.59 3.86 6.49

Competitive Comparison of BioNxt Solutions's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, BioNxt Solutions's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioNxt Solutions's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BioNxt Solutions's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where BioNxt Solutions's Debt-to-Asset falls into.



BioNxt Solutions Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

BioNxt Solutions's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

BioNxt Solutions's Debt-to-Asset for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioNxt Solutions  (XCNQ:BNXT) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


BioNxt Solutions Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of BioNxt Solutions's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


BioNxt Solutions (XCNQ:BNXT) Business Description

Traded in Other Exchanges
Address
1820 Fir Street, Suite 270, Vancouver, BC, CAN, V6J 3B1
BioNxt Solutions Inc is a cannabis company engaged in developing analytical testing, processing, and formulation capability in Canada. It is also engaged in research, cultivation, extraction, import, distribution, and manufacturing in Germany. The products of the company include Drug Delivery, Point-of-Care Diagnostics, and Psychedelics.

BioNxt Solutions (XCNQ:BNXT) Headlines

No Headlines